Dr. David Fairchild, senior vice president and chief medical officer of retail health at CVS Health, tells this week’s Video Forum about the company’s ongoing efforts to combat smoking, vaping and nicotine use. Drawing on the findings of a recent national survey, he discusses the dangers of high levels of consumption of such products by teenagers and young adults, as well as smoking cessation programs and the need to counter misinformation in the marketplace.
Video Forum: Dr. David Fairchild, CVS Health
The battle against tobacco and nicotine use continues.
Related
Video Forum: Sandra Hanna, Neighbourhood Pharmacies
Expanded scope of Rx practice benefits Canadians.
Video Forum: Tanvi Patel, Amazon Pharmacy
Harnessing technology to enhance the patient experience.
Video Forum: John Marraffa, Kinney Drugs
Regional chain succeeds in leveraging unique strengths.
Latest
Seya Health launches Full Fiber
Austin-based women's health brand debuts at $24.99 on Seyahealth.com and Amazon, with female-focused creatine and hormone support formulas set for pipeline rollout.
Uqora report highlights hidden toll of UTIs on women’s health and daily lives
According to Uqora's UTI Impact Report, nearly half of women are willing to take a proactive approach to urinary health, signaling growing interest in prevention rather than treatment alone.
Meijer expands acceptance of evermore OTC spend cards for Medicare members
Midwest retailer adds another convenient payment option for eligible shoppers
CVS to pay $315 million to resolve DOJ opioid prescription allegations
The settlement resolves a lawsuit filed in 2024 alleging that CVS filled medically unnecessary prescriptions for opioids and other controlled substances, contributing to the nation's ongoing opioid crisis.